These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8540736)

  • 41. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Plague].
    Kamiyama T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():453-8. PubMed ID: 12722261
    [No Abstract]   [Full Text] [Related]  

  • 43. [Plague in Algeria: about five strains of Yersinia pestis isolated during the outbreak of June 2003].
    Lounici M; Lazri M; Rahal K
    Pathol Biol (Paris); 2005 Feb; 53(1):15-8. PubMed ID: 15620604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative therapeutic effectiveness of bacteriomycin, biomycin, streptomycin, and gamma globulin in plague; experimental studies].
    SEMENOVA EL; KARTASHEVA AL; ABRAMOVA GF; LOPATUKHINA LG
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Mar; 28(3):119-22. PubMed ID: 13457226
    [No Abstract]   [Full Text] [Related]  

  • 45. Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects.
    Butler T; Bell WR; Nguyen-Ngoc-Linh ; Nguyen-Dinh-Tiep ; Arnold K
    J Infect Dis; 1974 May; 129():Suppl:S78-84. PubMed ID: 4825250
    [No Abstract]   [Full Text] [Related]  

  • 46. [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].
    Ryzhko IV; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2009; 54(5-6):37-40. PubMed ID: 20052916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent emergence of new variants of Yersinia pestis in Madagascar.
    Guiyoule A; Rasoamanana B; Buchrieser C; Michel P; Chanteau S; Carniel E
    J Clin Microbiol; 1997 Nov; 35(11):2826-33. PubMed ID: 9350742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study of trimethoprim sensitivity in strains of Yersinia pestis isolated from various natural foci of plague].
    Kravchenko AN; Mishan'kin BN
    Antibiot Khimioter; 1989 Jan; 34(1):42-6. PubMed ID: 2730213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of antibacterial therapy on the epidemic threat of experimental pneumonic plague in monkeys].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV
    Antibiot Khimioter; 2001; 46(4):16-8. PubMed ID: 11550501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of Yersinia pestis DNA adenine methyltransferase in vitro by a stibonic acid compound: identification of a potential novel class of antimicrobial agents.
    McKelvie JC; Richards MI; Harmer JE; Milne TS; Roach PL; Oyston PC
    Br J Pharmacol; 2013 Jan; 168(1):172-88. PubMed ID: 22889062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plague: Recognition, Treatment, and Prevention.
    Yang R
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29070654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance of Yersinia pestis to antimicrobial agents.
    Galimand M; Carniel E; Courvalin P
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3233-6. PubMed ID: 17005799
    [No Abstract]   [Full Text] [Related]  

  • 55. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].
    Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV
    Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens.
    Halasohoris SA; Scarff JM; Pysz LM; Lembirik S; Lemmon MM; Biek D; Hannah B; Zumbrun SD; Panchal RG
    J Antibiot (Tokyo); 2021 Dec; 74(12):884-892. PubMed ID: 34522025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen].
    Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu
    Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Resistance of experimental antibiotic resistant variants of Yersinia pestis EV76 (NIIEG line) to modern marker antibiotics].
    Ivanova VS; Morozova IV; Lebedeva SA
    Antibiot Khimioter; 2006; 51(11-12):18-23. PubMed ID: 18318143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of quinolones against Y. pestis].
    Kalininskiĭ VB; Vasil'ev NT; Iudin SM
    Antibiot Khimioter; 1989 Jul; 34(7):521-3. PubMed ID: 2818084
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Adamovicz JJ; Amemiya K; Fast RL; Miller L; Opal SM; Palardy J; Parejo NA; Sörgel F; Kinzig-Schippers M; Drusano GL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3276-84. PubMed ID: 24687492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.